The identification of novel proteins that interact with the GLP-1 receptor and restrain its activity

Molecular Endocrinology

Volumn 27, Issue 9, 2013, Pages 1550-1563

  Huang, X ^a   Dai, F F ^a   Gaisano, G ^a   Giglou, K ^a   Han, J ^d   Zhang, M ^a   Kittanakom, S ^b   Wong, V ^b   Wei, L ^d   Showalter, A D ^c   Sloop, K W ^c   Stagljar, I ^b   Wheeler, M B ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c ELI LILLY AND COMPANY   (United States)

^d SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AP2M1 PROTEIN; APLP1 PROTEIN; COMPLEMENTARY DNA; FORSKOLIN; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; INCRETIN; PROTEIN; SLC15A4 PROTEIN; SMALL INTERFERING RNA; UBIQUITIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL MATURATION; CELL METABOLISM; CHINESE HAMSTER; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; INSULIN RELEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ANIMALS; CHO CELLS; CRICETINAE; CRICETULUS; CYCLIC AMP; GLUCAGON-LIKE PEPTIDE 1; HEK293 CELLS; HUMANS; INSULIN; INSULIN-SECRETING CELLS; MICE; PROTEIN BINDING; PROTEIN INTERACTION MAPS; RECEPTORS, GLUCAGON; REPRODUCIBILITY OF RESULTS; TWO-HYBRID SYSTEM TECHNIQUES; UBIQUITIN;

EID: 84883231523     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2013-1047     Document Type: Article

References (34)

1. Drucker DJ. The biology of incretin hormones. Cell Metab. 2006; 3:153-165.
2. Baggio LL, Drucker DJ. Biology of incretins: GLP-1 and GIP. Gastroenterology. 2007;132:2131-2157.
3. Lovshin JA, Drucker DJ. Incretin-based therapies for type 2 diabetes mellitus. Nat Rev Endocrinol. 2009;5:262-269.
4. Ussher JR, Drucker DJ. Cardiovascular biology of the incretin system. Endocr Rev. 201233:187-215.
5. Brubaker PL, Drucker DJ. Structure-function of the glucagon receptor family of G protein-coupled receptors: the glucagon, GIP, GLP-1, and GLP-2 receptors. Receptors Channels. 2002;8:179-188.
6. Willard FS, Sloop KW. Physiology and emerging biochemistry of the glucagon-like peptide-1 receptor. Exp Diabetes Res. 2012; 2012:470851.
7. Bockaert J, Fagni L, Dumuis A, Marin P. GPCR interacting proteins (GIP). Pharmacol Therapeut. 2004;103:203-221.
8. Bockaert J, Roussignol G, Bécamel C, et al. GPCR-interacting proteins (GIPs): nature and functions. Biochem Soc Trans. 2004;32(Pt. 5):851-855.
9. Tilakaratne N, Sexton PM. G-Protein-coupled receptor-protein interactions: basis for new concepts on receptor structure and function. Clin Exp Pharmacol Physiol. 2005;32:979-987.
10. Sonoda N, Imamura T, Yoshizaki T, Babendure JL, Lu J-C, Olefsky JM. [Beta]-Arrestin-1 mediates glucagon-like peptide-1 signaling to insulin secretion in cultured pancreatic cells. Proc Natl Acad Sci USA. 2008;105:6614-6619.
11. Syme CA, Zhang L, Bisello A. Caveolin-1 regulates cellular trafficking and function of the glucagon-like peptide 1 receptor. Mol Endocrinol. 2006;20:3400-3411.
12. Schelshorn DW, Joly F, Mutel S, et al. Lateral allosterism in the glucagon receptor family: GLP-1 induces GPCR heteromer formation. Mol Pharmacol. 2011;81(3):309-318.
13. Iyer K, Bürkle L, Auerbach D, et al. Utilizing the split-ubiquitin membrane yeast two-hybrid system to identify protein-protein interactions of integral membrane proteins. Sci STKE. 2005; 2005:pl3.
14. Kittanakom S, Chuk M, Wong V, et al. Analysis of membrane protein complexes using the split-ubiquitin membrane yeast twohybrid (MYTH) system. Methods Mol Biol. 2009;548:247-271.
15. Pandey P, Harbinder S. The Caenorhabditis elegans D2-like dopamine receptor DOP-2 physically interacts with GPA-14, a Gαi subunit. J Mol Signal. 2012;7:3.
16. Rosemond E, Rossi M, McMillin SM, Scarselli M, Donaldson JG, Wess J. Regulation ofM3 muscarinic receptor expression and function by transmembrane protein 147. Mol Pharmacol. 2011;79: 251-261.
17. Jin J, Kittanakom S, Wong V, et al. Interaction of the mu-opioid receptor with GPR177 (Wntless) inhibits Wnt secretion: potential implications for opioid dependence. BMC Neurosci. 2010;11:33.
18. Dirnberger D, Messerschmid M, Baumeister R. An optimized split-ubiquitin cDNA-library screening system to identify novel interactors of the human Frizzled 1 receptor. Nucleic Acids Res. 2008;36:e37.
19. Ohno H, Nakatsu Y, Sakoda H, et al. 4F2hc stabilizes GLUT1 protein and increases glucose transport activity. AJP Cell Physiol. 2011;300:C1047-C1054.
20. Snider J, Kittanakom S, Damjanovic D, Curak J, Wong V, Stagljar I. Detecting interactions with membrane proteins using a membrane two-hybrid assay in yeast. Nat Protoc. 2010;5:1281-1293.
21. Gietz RD, Woods RA. Transformation of yeast by lithium acetate/ single-stranded carrier DNA/polyethylene glycol method. Meth Enzymol. 2002;350:87-96.
22. Adler J, Parmryd I. Quantifying colocalization by correlation: the Pearson correlation coefficient is superior to the Mander's overlap coefficient. Cytometry A. 2010;77:733-742.
23. Hardy AB, Fox JEM, Giglou PR, et al. Characterization of Erg K+ channels in alpha-and beta-cells of mouse and human islets. J Biol Chem. 2009;284:30441-30452.
24. Ilegems E, Iwatsuki K, Kokrashvili Z, Benard O, Ninomiya Y, Margolskee RF. REEP2 enhances sweet receptor function by recruitment to lipid rafts. J Neurosci. 2010;30:13774-13783.
25. +2 sensor protein visinin-like protein-1 is expressed in pancreatic islets and regulates insulin secretion. J Biol Chem. 2006;281:21942-21953.
26. Bennett K, James C, Hussain K. Pancreatic β-cell KATP channels: hypoglycaemia and hyperglycaemia. Rev Endocr Metab Disord. 2010;11:157-163.
27. Panjwani N, Mulvihill EE, Longuet C, et al. GLP-1 receptor activation indirectly reduces hepatic lipid accumulation but does not attenuate development of atherosclerosis in diabetic male ApoE(α/β) mice. Endocrinology. 2013;154:127-139.
28. MacDonald PE, El-Kholy W, Riedel MJ, Salapatek AMF, Light PE, Wheeler MB. The multiple actions of GLP-1 on the process of glucose-stimulated insulin secretion. Diabetes. 2002;51(suppl 3): S434-S442.
29. Kottra G, Daniel H. The proton oligopeptide cotransporter family SLC15 in physiology and pharmacology. Arch Eur J Physiol. 2004; 447:610-618.
30. Ghanouni P, Schambye H, Seifert R, et al. The effect of pH on beta(2) adrenoceptor function. Evidence for protonation-dependent activation. J Biol Chem. 2000;275:3121-3127.
31. Takeuchi F, Ochiai Y, Serizawa M, et al. Search for type 2 diabetes susceptibility genes on chromosomes 1q, 3q and 12q. J Hum Genet. 2008;53:314-324.
32. Weber B, Schaper C, Scholz J, Bein B, Rodde C, Tonner P. Interaction of the amyloid precursor like protein 1 with the 2Aadrenergic receptor increases agonist-mediated inhibition of adenylate cyclase. Cell Signal. 2006;18:1748-1757.
33. Radhakrishnan K, Krieger A, Dibué M, Hescheler J, Schneider T. APLP1 and Rab5A interact with the II-III loop of the voltage-gated Ca-channel Ca(v)2.3 and modulate its internalization differently. Cell Physiol Biochem. 2011;28:603-612.
34. Owen DJ, Collins BM, Evans PR. Adaptors for clathrin coats: structure and function. Annu Rev Cell Dev Biol. 2004;20:153-191.